Condition

Recurrent Cancer clinical trials and research

• 9Clinical trials
• 9Countries

Newest Recurrent Cancer clinical trials

All recruiting trials (9)

• Personalized neoantigen peptide vaccine for solid tumors

  This trial will test whether a custom neoantigen peptide vaccine given with poly-ICLC and an anti-PD-1 drug can help the immune system fight solid tumors in adults with advanced or high-risk disease.

  Recruiting Phase 1/2 Seqker Biosciences, Inc. · Bangkok · NCT07002203

• Spatially fractionated radiation for gynecologic cancers

  This will try spatially fractionated radiation after external beam therapy to control cervical cancer or pelvic recurrences in people who can't have standard brachytherapy.

  Recruiting Tata Memorial Hospital · Navi Mumbai, Maharashtra · NCT06644846

• Targeted therapies for childhood and adolescent cancer

  This study is testing if new targeted treatments based on the genetic makeup of tumors can help kids and teens with cancer feel better and improve their chances of recovery.

  Recruiting at 12 sites Phase 1/2 Australian & New Zealand Children's Haematology/Oncology Group · Newcastle, New South Wales and 13 other locations · NCT06208657

• Treatment for recurrent and refractory solid tumors using IMA402

  This study is testing a new treatment called IMA402 to see if it can help people with advanced solid tumors that haven't responded to other therapies.

  Recruiting at 24 sites Phase 1/2 Immatics Biotechnologies GmbH · Heidelberg, Baden-Wurttemberg and 28 other locations · NCT05958121

• Preventing second cancers with Dostarlimab treatment

  This study is testing if the drug Dostarlimab can help prevent second cancers in people who are at high risk after finishing treatment for their first cancer.

  Recruiting at 5 sites Phase 2 Centre Leon Berard · Caen and 4 other locations · NCT05855811

• Using SBRT for reirradiation of ultra-central thoracic tumors

  This study is testing if a special type of radiation therapy called SBRT can safely treat patients with tough-to-reach lung tumors that have come back after previous radiation.

  Recruiting Peking University Third Hospital · Beijing, Beijing Municipality · NCT05189054

• Combination therapy for recurrent primary central nervous system lymphoma

  This study is testing a new combination of three medications to see if it can help people with recurrent primary central nervous system lymphoma feel better after their previous treatments didn't work.

  Recruiting at 3 sites Phase 1/2 Dana-Farber Cancer Institute · Boston, Massachusetts and 3 other locations · NCT04421560

• Using cabozantinib to treat liver cancer that has returned after transplant

  This study is testing if cabozantinib can help people with liver cancer that has come back after a liver transplant.

  Recruiting Phase 2 University Health Network, Toronto · Toronto, Ontario · NCT04204850

• Treatment for recurrent and refractory solid tumors using engineered T-cells and nivolumab

  This study is testing a new treatment using specially designed T-cells and a drug called nivolumab to see if it can help people with tough-to-treat solid tumors.

  Recruiting at 21 sites Phase 1/2 Immatics US, Inc. · Stanford, California and 20 other locations · NCT03686124

Related topics

Quick answers

How many Recurrent Cancer clinical trials are recruiting right now?

9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 9 countries. The most sites are in Canada (2 trials), United States (2 trials), Germany (2 trials), France (1 trial), India (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 5, Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →